Blog: BETTER THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On September 13, 2022, Better Therapeutics, Inc. (the “Company”) presented a
corporate presentation at the H.C. Wainwright 24th Annual Global Investment
Conference. A copy of the corporate presentation is filed as Exhibit 99.1 to
this Current Report on Form 8-K. The corporate presentation will also be
available on the Company’s website in the Investors section at

The information contained in Item 7.01 in this Current Report on Form 8-K and
Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Number       Description

99.1           Corporate Presentation of Better Therapeutics, Inc., dated
             September 13, 2022.

104          Cover Page Interactive Data File (embedded within the Inline XBRL


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s